# A Study of a FimH Blocker, EB8018, in Crohn's Disease Patients

> **NCT03709628** · PHASE1 · COMPLETED · sponsor: **Enterome** · enrollment: 8 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** EB8018 (First-in-class FimH blocker)

## Key facts

- **NCT ID:** NCT03709628
- **Lead sponsor:** Enterome
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-07
- **Primary completion:** 2019-11-12
- **Final completion:** 2019-12-04
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03709628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03709628, "A Study of a FimH Blocker, EB8018, in Crohn's Disease Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03709628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*